Company & Sponsor Intelligence

The University of Texas Health Science Center at San Antonio

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting3

Completed3

Countries1

Therapeutic footprint

adhdalzheimerspain_neuropathyparkinsons

Indexed studies

NCT04200911Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway
alzheimers · United StatesEARLY_PHASE1

NCT05592678δ in Dementia Clinical Trials
alzheimers · United StatesNA

NCT04680000Chronic Pain Management In Primary Care Using Behavioral Health Consultants
pain_neuropathy · United StatesNA

NCT04063124Senolytic Therapy to Modulate Progression of Alzheimer's Disease
alzheimers · United StatesPHASE1, PHASE2

NCT00778310Neuroimaging of the Effects of Concerta in the Treatment of ADHD
adhd · United StatesPHASE4

NCT06133283Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD
parkinsons · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →